what is cryptocurrency worth, Featured

Pfizer announced an increase in its quarterly dividend, and American pharmaceutical giant Pfizer said on Thursday that it would increase its quarterly dividend by 2.4%, from 42 cents to 43 cents per share. The new dividend is equivalent to $1.72 per year, which means that the annual yield is about 6.8%. Albert Bourla, CEO of Pfizer, said that the dividend increase highlighted the company's strong financial performance, execution and commitment to return capital to shareholders.Bank of Japan: The confidence index of large manufacturers rose to the highest level since March 2022.Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.

The Australian stock market fell for the fourth consecutive trading day, led by mining stocks. The Australian stock market fell with the US stock market on Friday, with mining stocks falling the most. The day before, the unemployment rate in Australia fell sharply in November, prompting investors to reduce their bets on interest rate cuts in February. Australia's S&P/ASX 200 index fell 0.7% to 8276.5, the fourth consecutive trading day. The benchmark fell by about 1.6% this week, the biggest weekly decline since early August.Thirteen companies disclosed the progress of repurchase, among which Green Energy Huichong and Ruike had the highest amount of laser repurchase plans. On December 13th, a total of 13 companies issued announcements on stock repurchase. Among them, two companies disclosed the stock repurchase plan for the first time, four companies disclosed the progress of the implementation of stock repurchase, and seven companies have completed the implementation of the repurchase plan. Judging from the initial disclosure of the repurchase plan, Green Energy Huichong and Ruike Laser have the highest amount of repurchase plans, with the planned repurchase not exceeding 1.115 million yuan and 487,900 yuan respectively. Judging from the implementation progress of repurchase, Yuanli Technology, Jiuli Special Materials and Jack have the highest share repurchase amounts, with 33.1077 million yuan, 30.9807 million yuan and 3.2323 million yuan respectively. Judging from the completed repurchase, a total of one company repurchased more than 10 million on that day. Aerospace Rainbow, Aerospace Rainbow and Guanshi Technology have completed the highest repurchase amount, with 33.2989 million yuan, 2.479 million yuan and 2.1642 million yuan respectively.Citic Jiantou Pharmaceutical's 2025 strategy: looking for new additions and integration opportunities. Citic Jiantou said that looking forward to 2025, the reform policy in the medical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations as a whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.

The troops stationed in Macao are the anchor of maintaining prosperity and stability. This year marks the 25th anniversary of Macao's return to the motherland. Senior Colonel Wu Qian, director of the Information Bureau of the Ministry of National Defense and spokesman of the Ministry of National Defense, said today that the troops stationed in Macao are an important manifestation of national sovereignty. In the past 25 years, especially since the 18th National Congress of the Communist Party of China, the troops stationed in Macao have resolutely implemented the policy of "one country, two systems", conscientiously implemented the Basic Law and the Garrison Law, comprehensively strengthened army building, successfully fulfilled various tasks centered on defense, and effectively safeguarded national sovereignty, security and Macao's prosperity and stability. Looking forward to the future, the troops stationed in Macao will always be loyal guardians assured by the Party and the people, the powerful force of Haojiang trusted by Macao compatriots, and the "anchor needle" for maintaining Macao's prosperity and stability. (CCTV military)The dollar rose to 152.91 yen against the yen, the highest since November 27.CITIC Jiantou: With the increase of policy stimulus, the pro-cyclical catering chain is expected to take the lead in benefiting from the expected improvement. According to CITIC Jiantou Research Report, since September, heavy meetings have continuously released a clear policy signal to strive to achieve the goals and tasks of economic and social development throughout the year, and policies such as lowering the standard, reducing interest rates, lowering the mortgage interest rate, supporting local governments to resolve government affairs risks, issuing special government bonds to supplement core Tier 1 capital, using various tools to promote the real estate market to stop falling and stabilize, and increasing support and guarantee for key groups have been released one after another. Focusing on boosting consumption and expanding effective domestic demand, the food and beverage industry is expected to usher in an inflection point, and its performance and valuation are expected to continue to improve. The liquor sector is expected to rebound with the boost of the domestic economy and the activation of household consumption, and the business scene and mass consumption boom will return to the consumption upgrading channel, and the profitability of leading liquor companies is expected to accelerate the repair. At present, the overall valuation of the liquor sector is still at a low level, and the long-term investment value is prominent. With the increase of policy stimulus, the pro-cyclical catering chain is expected to take the lead in benefiting from the expected improvement. Continue to be optimistic: 1) The leisure snacks and beverage industries maintain a high degree of prosperity, and new channels bring important incremental opportunities to companies in the industry; 2) Combined with the catering channels that are recovering continuously, it is suggested to pay attention to condiments, beer and catering chain labels with innovative products or reform expectations. At the same time, the current market price of molasses has further dropped from the previous month, which is of great help to yeast enterprises to improve their profit elasticity. 3) The inflection point of the raw milk cycle is approaching, the gift scene is expected to be repaired, and the dairy products continue to upgrade their structure, with high dividends and outstanding cost performance.